2m 2m 2m 2m 2m 2m 2m
TG Therap (TGTX)
NASDAQ
$52.71-$0.49 (-0.93%)
Price as of Oct 22, 2026 7:41 PM EDT- $8.1BMarket Cap
- 53.80%1-Year Change
- BiotechnologyIndustry
TG Therap (TGTX)
$52.71-$0.49 (-0.93%)
TGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.20 | ||
Change | -$1.33 (-2.44%) | ||
Open | $54.51 | ||
High | $54.95 | ||
Low | $52.73 | ||
Previous Close | $54.53 | ||
Volume | 1,178,071 | ||
30-Day Average Volume | 1,598,679 | ||
1-Week Change | -2.15% | ||
1-Month Change | -6.93% | ||
1-Year Change | 53.80% | ||
3-Year Change | 688.15% | ||
5-Year Change | 67.24% | ||
Fundamentals | |||
Shares Outstanding | 153.1M | ||
Total Assets | $1.6B | ||
Market Cap | $8.1B | ||
Enterprise Value | $8.4B | ||
Period: QTR TTM FY | |||
Revenue | $235.8M | ||
Net Income | $7.8M | ||
Free Cash Flow | $39.0M | ||
EBIT | $10.2M | ||
EBITDA | $10.3M | ||
Net Working Capital | $877.2M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 817 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 13 | ||
P/E | 1,064 | ||
PEG | -18 | ||
Price/Free Cash Flow | 209 | ||
Price/Operating Cash Flow | 207 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 56.25 | ||
Last Split Date | 04/30/2012 | ||
Earnings & Revenue